Virus persistence after recovery from acute Lassa fever in Nigeria: a 2-year interim analysis of a prospective longitudinal cohort study-Reference-Cited by-同舟云学术

Virus persistence after recovery from acute Lassa fever in Nigeria: a 2-year interim analysis of a prospective longitudinal cohort study

Published:2022-01 Issue:1 Volume:3 Page:e32-e40
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Thielebein Anke,Ighodalo Yemisi,Taju Abubakar,Olokor Thomas,Omiunu Racheal,Esumeh Rita,Ebhodaghe Paulson,Ekanem Anieno,Igenegbale Ganiyu,Giwa Rosemary,Renevey Annick,Hinzmann Julia,Müller Jonas,Pallasch Elisa,Pahlmann Meike,Guedj Jeremie,Nwatuzor Joy,Femi Babatunde Oluwasola,Adomeh Donatus I,Asogun Danny,Akpede Nosa,Okogbenin Sylvanus,Günther Stephan,Oestereich Lisa,Duraffour Sophie,Ogbaini-Emovon Ephraim

Funder

German Research Foundation

German Federal Ministry of Health

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference27 articles.

1. Lassa fever: epidemiology, clinical features, diagnosis, management and prevention;Asogun;Infect Dis Clin North Am,2019

2. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study;Okokhere;Lancet Infect Dis,2018

3. Caseload and case fatality of Lassa fever in Nigeria, 2001–2018: a specialist center's experience and its implications;Akpede;Front Public Health,2019

4. Clinical sequencing uncovers origins and evolution of Lassa virus;Andersen;Cell,2015

5. Genomic analysis of Lassa virus during an Increase in cases in Nigeria in 2018;Siddle;N Engl J Med,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses;Cell Reports;2024-09

2. Global wastewater surveillance for pathogens with pandemic potential: opportunities and challenges;The Lancet Microbe;2024-08

3. Shortening the long-COVID: An exploratory review on the potential of Unani medicines in mitigating post-Covid-19 sequelae;Phytomedicine Plus;2024-05

4. Treatment of highly virulent mammarenavirus infections—status quo and future directions;Expert Opinion on Drug Discovery;2024-04-12

5. Lassa virus persistence with high viral titers following experimental infection in its natural reservoir host, Mastomys natalensis;2024-04-04